BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38330678)

  • 1. Assessing Adequacy: A Meta-Analysis of Rapid Onsite Evaluation of Thyroid Nodules.
    Issa PP; McCarthy C; Hussein M; Albuck AL; Emad E; Shama M; Moroz K; Toraih E; Kandil E
    J Surg Res; 2024 Apr; 296():523-531. PubMed ID: 38330678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration.
    Fawcett C; Eppenberger-Castori S; Zechmann S; Hanke J; Herzog M; Savic Prince S; Christ ER; Ebrahimi F
    Acta Cytol; 2022; 66(5):371-378. PubMed ID: 35512664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid onsite evaluation improves the adequacy of fine-needle aspiration for thyroid lesions: a systematic review and meta-analysis.
    Witt BL; Schmidt RL
    Thyroid; 2013 Apr; 23(4):428-35. PubMed ID: 23043247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid on-site evaluation of fine needle aspiration specimens by cytology scientists: a review of 3032 specimens.
    Shield PW; Cosier J; Ellerby G; Gartrell M; Papadimos D
    Cytopathology; 2014 Oct; 25(5):322-9. PubMed ID: 24844295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Rapid On-Site Evaluation on the Quality and Diagnostic Value of Thyroid Nodule Fine-Needle Aspirations.
    Muri R; Trippel M; Borner U; Weidner S; Trepp R
    Thyroid; 2022 Jun; 32(6):667-674. PubMed ID: 35236111
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of rapid on-site evaluation for ultrasound-guided thyroid fine needle aspiration.
    Jiang D; Zang Y; Jiang D; Zhang X; Zhao C
    J Int Med Res; 2019 Feb; 47(2):626-634. PubMed ID: 30463462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal timing for a repeat fine-needle aspiration biopsy of thyroid nodule following an initial nondiagnostic fine-needle aspiration.
    Deniwar A; Hammad AY; Ali DB; Alsaleh N; Lahlouh M; Sholl AB; Moroz K; Aslam R; Thethi T; Kandil E
    Am J Surg; 2017 Feb; 213(2):433-437. PubMed ID: 27475222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telecytology rapid onsite evaluation, with real-time communication between cytopathologist, cytotechnologist, and proceduralist, offers better adequacy rates for lymph node, but not thyroid, fine-needle aspirations.
    Post R; Doxzon K; Goldberg A
    J Am Soc Cytopathol; 2023; 12(6):407-414. PubMed ID: 37620222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Diagnostic Rates and Concordance with Subsequent Surgical Resections between Conventional Smear and ThinPrep Preparations versus ThinPrep Only in Thyroid Fine Needle Aspiration (T-FNA) Specimens.
    Rufail M; Jing X; Smola B; Heider A; Cantley R; Pang JC; Lew M
    Acta Cytol; 2022; 66(1):36-45. PubMed ID: 34753139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that Influence Sample Adequacy in Liquid-Based Cytology after Ultrasonography-Guided Fine-Needle Aspiration of Thyroid Nodules: A Single-Center Study.
    Lee YJ; Kim DW; Jung SJ; Baek HJ
    Acta Cytol; 2018; 62(4):253-258. PubMed ID: 29393083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
    Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors Influencing the Sample Adequacy of Ultrasound-Guided Fine-Needle Aspiration from Solid Thyroid Nodules for Liquid-Based Cytology: A Demographic, Sonographic, and Technical Perspective.
    Fu Y; Sun Y; Pei Q; Han X; Qin W; Mei F; Tan S; Cui L
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound improves the potency of fine-needle aspiration in thyroid nodules with high inadequate risk.
    Yin T; Zheng B; Lian Y; Li H; Tan L; Xu S; Liu Y; Wu T; Ren J
    BMC Med Imaging; 2022 May; 22(1):83. PubMed ID: 35501723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification.
    Jiang W; Phillips SA; Newbury RO; Naheedy JH; Newfield RS
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):449-455. PubMed ID: 33629571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy: diagnostic yield and the value of onsite cytopathological assessment.
    Khan MA; Grimm IS; Ali B; Nollan R; Tombazzi C; Ismail MK; Baron TH
    Endosc Int Open; 2017 May; 5(5):E363-E375. PubMed ID: 28497108
    [No Abstract]   [Full Text] [Related]  

  • 16. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
    Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
    Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditions associated with the need for additional needle passes in ultrasound-guided thyroid fine-needle aspiration with rapid on-site pathology evaluation.
    Zargham R; Johnson H; Anderson S; Ciolino A
    Diagn Cytopathol; 2021 Jan; 49(1):105-108. PubMed ID: 32870607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance.
    Hall EA; Hartzband P; VanderLaan PA; Nishino M
    Cancer Cytopathol; 2023 May; 131(5):313-324. PubMed ID: 36792948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experience.
    Ghofrani M; Beckman D; Rimm DL
    Cancer; 2006 Apr; 108(2):110-3. PubMed ID: 16400635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.